Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 2/20 | 0.41 |
| ▸ | PLG | P00747 | 1/20 | 0.41 |
| ▸ | PLAT | P00750 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 9/20 | 0.39 |
| ▸ | BCL2 | P10415 | 1/20 | 0.39 |
| ▸ | BRAF | P15056 | 2/20 | 0.39 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 2/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2880155 | 0.83 | PLK1 (0.43) | ABCG2BRAFABCB1FYN | |
| SCHEMBL2881795 | 0.83 | PLK1 (0.44) | ABCG2PIK3CA | |
| SCHEMBL2876734 | 0.81 | BCDIN3D (0.42) | PLAUPLGPLATABCG2BRAF | |
| SCHEMBL2881793 | 0.77 | CSNK2A1 (0.46) | PLAUPLGPLATABCB1SMN1; SMN2 | |
| SCHEMBL2876730 | 0.76 | PLAU (0.52) | PLAUPLGPLATPIK3CASMN1; SMN2 | |
| SCHEMBL2881428 | 0.76 | FYN (0.51) | ABCG2BRAFABCB1FYN | |
| SCHEMBL2213283 | 0.76 | PLG (0.42) | PLAUPLGPLATBCL2ABCB1 | |
| SCHEMBL2215485 | 0.73 | PLAU (0.42) | PLAUPLGPLATSLC2A1SMN1; SMN2 | |
| SCHEMBL2216413 | 0.73 | CYP17A1 (0.49) | ABCG2BRAFABCB1FYN | |
| SCHEMBL2253893 | 0.73 | PLG (0.44) | PLAUPLGPLATABCG2ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1797096-B1 | PYRAZOLOPYRIMIDINES AS INHIBITORS OF PROTEIN KINASE B (AKT) | BAYER SCHERING PHARMA AG (DE) | 2011-07-27 | — | — | EP | disclosed |